SCHEMBL21756750

SCHEMBL21756750

CN(O)C(=O)C1CC=CCC1C=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 2/20 0.31
▸ MCL1 Q07820 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11792052 0.74 POLB (0.39) —
SCHEMBL7304361 0.72 — —
SCHEMBL6085256 0.72 ALDH1A1 (0.33) —
SCHEMBL15188991 0.72 GRM4 (0.35) —
SCHEMBL6085264 0.72 ALDH1A1 (0.33) —
SCHEMBL6085259 0.72 ALDH1A1 (0.33) —
SCHEMBL19908097 0.69 — —
SCHEMBL10139309 0.67 — —
SCHEMBL12597887 0.67 — —
SCHEMBL10433083 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050883-B1 PRODUCTION METHOD FOR DIAZABICYCLOOCTANE DERIVATIVES AND INTERMEDIATES MEIJI SEIKA PHARMA CO LTD (JP) 2020-04-22 — — EP disclosed
EP-3613741-A1 PREPARATION OF A DIAZABICYCLOOCTANE DERIVATIVE Meiji Seika Pharma Co., Ltd. (JP) 2020-02-26 — — EP disclosed
EP-3613740-A1 PREPARATION OF A DIAZABICYCLOOCTANE DERIVATIVE Meiji Seika Pharma Co., Ltd. (JP) 2020-02-26 — — EP disclosed
Send feedback